搜索优化
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
过去 7 天
时间不限
过去 1 小时
过去 24 小时
过去 30 天
按相关度排序
按时间排序
autobuzz.my
23 小时
CKD Omoda C9 by Jaecoo rolls out of Chery’s Shah Alam plant – Malaysia deliveries to ...
Good news - if you ordered an Omoda C9, you will be getting your shiny new car soon! Jaecoo Malaysia has announced the ...
Too Old to Operate
2 天
CKD Subgroups and Mortality Risks Identified Through Clustering Techniques
The following is a summary of “Use of consensus clustering to identify distinct subtypes of chronic kidney disease and ...
腾讯网
17 小时
共识解读:糖尿病合并慢性肾脏病患者如何制定综合管理策略?
基于共识,共建科学管理方案!相较于2020年版《中国2型糖尿病防治指南》[1],我国成人糖尿病患病率已从11.2%上升至12.4%,其中2型糖尿病占据主要比例。尤为引人关注的是,这一患者群体中大约30%-40%面临发展为慢性肾脏病(CKD)的风险,而 ...
腾讯网
1 天
2024 ASN研究速递丨阐明SGLT2抑制剂在非糖尿病CKD患者中的肾脏保护作用
慢性肾脏病(CKD)是近年来国际热议的话题,其患病率逐年上升,已成为我国乃至全球的重大公共卫生问题。钠-葡萄糖协同转运蛋白2(SGLT2) 抑制剂是一类治疗CKD的药物,已被多篇国内外指南/共识列为1A类推荐,无论患者是否合并糖尿病。尽管SGLT2抑制剂在临床中的疗效已得到广泛认可,其作用于肾脏疾病的具体机制尚未完全阐明。
来自MSN
1 天
All CKD buses must be fitted with speed limiters from 2026
Deputy prime minister Ahmad Zahid Hamidi says 5,939 road fatalities have been reported up until November this year, mostly ...
11 小时
Novo Nordisk's Ozempic Label Expansion Snags Approval From European Drug Regulator's ...
Novo Nordisk's Ozempic gains positive EMA opinion for label update after FLOW trial data show significant kidney and ...
3 小时
基于FLOW肾脏结局试验的积极数据 诺和诺德司美格鲁肽更新标签获EMA支持
诺和诺德(Novo Nordisk) (NVO.US)今日宣布,欧洲药品管理局(EMA)人用药品委员会(CHMP)已对其重磅疗法Ozempic(司美格鲁肽,semaglutide)更新标签纳入降低肾病相关事件风险的信息发布了积极意见,该决定基于FLOW肾脏结局试验的积极数据。 根据新闻稿 , Ozempic将可能成为可降低2型糖尿病伴慢性肾病(CKD)成人患者肾病进展风险的首个GLP-1受体激动剂 ...
emjreviews.com
2 天
Alpha Blockers for Voiding Dysfunction Raise Fracture Risk in Women with CKD
Alpha blockers prescribed for voiding dysfunction significantly increase fracture risk in women with chronic kidney disease.
Autocar India on MSN
18 小时
2025 Skoda Kodiaq could be offered in multiple trims
New Skoda Kodiaq in second generation guise will launch between April-June 2025; is expected to be offered in multiple trims.
Too Old to Operate
2 天
Prevalence and Impact of CAN in Nondiabetic CKD
The following is a summary of “Cardiovascular autonomic neuropathy in chronic kidney disease: a study of kidney biopsy cases,” published in the December 2024 issue of Nephrology by Kuno et al.
thecardiologyadvisor.com
1 天
Infections, CV Events Tied to Poor Dental Care in Advanced CKD, Dialysis
Clinicians treating patients with kidney disease must be aware of dental considerations to avoid potentially lethal consequences.
BioSpace
12 小时
Novo Nordisk Snags Kidney Disease Expansion for Ozempic in Europe
The EMA approved a kidney disease–related label expansion for the blockbuster GLP-1 drug after a study showed reduced risk of ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈